Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec;46(2):2423845.
doi: 10.1080/0886022X.2024.2423845. Epub 2024 Nov 14.

Noninvasive genetic testing for type IV collagen nephropathy using oral mucosa DNA sampling in children with haematuria

Affiliations

Noninvasive genetic testing for type IV collagen nephropathy using oral mucosa DNA sampling in children with haematuria

Jiaojiao Liu et al. Ren Fail. 2024 Dec.

Abstract

Objective: Hematuria is one of the most common conditions in children, and increase the risk of chronic kidney disease. Persistent hematuria may be the earliest manifestation of type IV collagen-related nephropathy. Early diagnosis is essential for optimized therapy. Due to the invasive nature of kidney biopsy and the high cost of whole exome sequencing, its application in the diagnosis of isolated hematuria is rare. Hence, we performed noninvasive and convenient genetic testing approaches for type IV collagen-related nephropathy.

Methods: We used noninvasive oral mucosa sampling as an alternative method for DNA isolation for genetic testing and designed a panel targeting three type IV collagen nephropathy-related genes in children with hematuria. Children with persistent hematuria unaccompanied by clinically significant proteinuria or renal insufficiency who underwent genetic testing using a hematuria panel were enrolled.

Results: Thirty-seven of 112 (33.0%) patients were found to have a genetic variant in COL4A3/A4/A5. Pathogenic/likely pathogenic COL4A3/A4/A5 variants were identified in 17 of the 112 patients analyzed (15.2%), which were considered to explain their hematuria manifestations. In addition, variants of unknown significance (VUSs) were found in 17.8% (20/112) of patients. Furthermore, we observed a much greater COL4A3/A4/A5 variant detection rate in patients with a positive family history or more severe hematuria (RBC ≥ 20/HP) or with coexisting microalbuminuria (59.2% vs. 12.7%, p < 0.001; 64.0% vs. 24.1%, p < 0.001; 66.7% vs. 30.1%, p = 0.025).

Conclusions: We present the high prevalence of variants in COL4A genes in a multicenter pediatric cohort with hematuria, which requires close monitoring and long-term follow-up.

Keywords: Hematuria; genetic testing; pediatric; type IV collagen-related nephropathy.

PubMed Disclaimer

Conflict of interest statement

The authors report there are no competing interests to declare.

Figures

Figure 1.
Figure 1.
Results of COL4A3/A4/A5 sequencing in 112 children with hematuria. Negative, with no variants detected; P/LP, pathogenic or likely pathogenic variants; VUS, variant of uncertain significance.

Similar articles

References

    1. Vehaskari VM, Rapola J, Koskimies O, et al. . Microscopic hematuria in school children: epidemiology and clinicopathologic evaluation. J Pediatr. 1979;95(5 Pt 1):676–684. doi: 10.1016/s0022-3476(79)80710-6. - DOI - PubMed
    1. Zhai YH, Xu H, Zhu GH, et al. . Efficacy of urine screening at school: experience in Shanghai, China. Pediatr Nephrol. 2007;22(12):2073–2079. doi: 10.1007/s00467-007-0629-5. - DOI - PubMed
    1. Murakami M, Yamamoto H, Ueda Y, et al. . Urinary screening of elementary and junior high-school children over a 13-year period in Tokyo. Pediatr Nephrol. 1991;5(1):50–53. doi: 10.1007/bf00852844. - DOI - PubMed
    1. Zhong X, Ding J, Wang Z, et al. . Risk factors associated with abnormal urinalysis in children. Front Pediatr. 2021;9:649068. doi: 10.3389/fped.2021.649068. - DOI - PMC - PubMed
    1. Zhou L, Xi B, Xu Y, et al. . Clinical, histological and molecular characteristics of Alport syndrome in Chinese children. J Nephrol. 2023;36(5):1415–1423. doi: 10.1007/s40620-023-01570-7. - DOI - PubMed